{"id":"W4383058531","doi":"10.1002/ueg2.12436","title":"Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?","year":2023,"lang":"en","type":"editorial","venue":"United European Gastroenterology Journal","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Genentech; Novo Nordisk; AstraZeneca; UCB Pharma; Pfizer","keywords":"Medicine; Disease; Ulcerative colitis; Mesalazine; Internal medicine; Gastroenterology; Clinical trial; Inflammatory bowel disease; Clinical endpoint; Retrospective cohort study; Quality of life (healthcare); Psoriasis; Post-hoc analysis; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001312395,0.0005151271,0.0002733614,0.000335679,0.0003166189,0.0001569654,0.001050419,0.0002671263,0.00008096787],"category_scores_gemma":[0.000643711,0.0004145569,0.0002985874,0.0001330657,0.0003823498,0.00001104328,0.0003166932,0.001780342,0.0002328065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007644534,"about_ca_system_score_gemma":0.0002607903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003678246,"about_ca_topic_score_gemma":0.00007031374,"domain_scores_codex":[0.9945433,0.002876894,0.0006730906,0.0005933932,0.0004318418,0.0008815238],"domain_scores_gemma":[0.9980208,0.00009332206,0.0004805889,0.000661989,0.0003877405,0.0003555164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.009688095,0.000090125,0.009959666,0.00004191043,0.0003308418,0.003096448,0.0001893699,0.0006197069,0.00006161644,0.000005681036,0.9758406,0.00007599089],"study_design_scores_gemma":[0.002557789,0.0003942793,0.5054098,0.0001976751,0.0001316754,0.00005192566,0.0001039006,0.0002102675,0.000006585779,0.00006800023,0.4905459,0.0003221999],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.2483404,0.0004602825,0.0005235351,0.001622661,0.7456439,0.0008427771,0.00177829,0.0001024351,0.0006857695],"genre_scores_gemma":[0.1196133,0.003180152,0.0001437401,0.008423761,0.860648,0.00008002158,0.003288612,0.0007362175,0.003886216],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.4954502,"threshold_uncertainty_score":0.9998306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007845484166055438,"score_gpt":0.2431171967631602,"score_spread":0.2352717125971047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}